{"entity":{"type":"insider","cik":"0001362942","url":"/insider/0001362942","json_url":"/insider/0001362942.json","name":"Weller Harry R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":24,"first":"2011-11-22","last":"2016-10-31","span_basis":"filed_date"},"name_variants":[{"name":"Weller Harry R","source":"filing","n_filings":24,"first_seen":"2011-11-22","last_seen":"2016-10-31"}],"transactions":[{"id":3258819,"accession":"0001209191-16-147491","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-147491","line_url":"/filing/0001209191-16-147491#line-5","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":435.0,"shares_display":"435","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5655.0,"total_display":"5,655.00","total_whole":"5,655","shares_owned_after":80223.0,"shares_owned_after_display":"80,223","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-10-31","scope":"insider"},{"id":3258813,"accession":"0001209191-16-147491","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-147491","line_url":"/filing/0001209191-16-147491#line-4","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":338462.0,"shares_display":"338,462","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":4400006.0,"total_display":"4,400,006.00","total_whole":"4,400,006","shares_owned_after":3490073.0,"shares_owned_after_display":"3,490,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-10-31","scope":"insider"},{"id":2211012,"accession":"0001209191-16-134938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-134938","line_url":"/filing/0001209191-16-134938#line-1","is_derivative":false,"issuer_cik":"0001037649","issuer_name":"INTERLEUKIN GENETICS INC","issuer_ticker":"ILIU","issuer_name_source":null,"issuer_url":"/issuer/0001037649","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20120724.0,"shares_display":"20,120,724","price_per_share":0.0994,"price_display":"0.10","price_state":"stated","total_value":1999999.9656,"total_display":"1,999,999.97","total_whole":"2,000,000","shares_owned_after":55418811.0,"shares_owned_after_display":"55,418,811","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-07-29","filed_date":"2016-08-02","scope":"insider"},{"id":2108840,"accession":"0001209191-16-133494","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-133494","line_url":"/filing/0001209191-16-133494","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1527301.0,"shares_display":"1,527,301","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":13333337.73,"total_display":"13,333,337.73","total_whole":"13,333,338","shares_owned_after":2665520.0,"shares_owned_after_display":"2,665,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-07-18","filed_date":"2016-07-20","scope":"insider","n_lines":2},{"id":2177883,"accession":"0001209191-16-109547","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-109547","line_url":"/filing/0001209191-16-109547","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1420858.0,"shares_display":"1,420,858","price_per_share":35.19,"price_display":"35.19","price_state":"stated","total_value":49999993.02,"total_display":"49,999,993.02","total_whole":"49,999,993","shares_owned_after":9564684.0,"shares_owned_after_display":"9,564,684","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-03-18","filed_date":"2016-03-18","scope":"insider","n_lines":2},{"id":2816976,"accession":"0001209191-16-091437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-091437","line_url":"/filing/0001209191-16-091437","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":1901869.0,"shares_owned_after_display":"1,901,869","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-01-13","filed_date":"2016-01-14","scope":"insider","n_lines":2},{"id":2043646,"accession":"0001209191-16-091075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-091075","line_url":"/filing/0001209191-16-091075#line-1","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1111111.0,"shares_display":"1,111,111","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":9999999.0,"total_display":"9,999,999.00","total_whole":"9,999,999","shares_owned_after":5854351.0,"shares_owned_after_display":"5,854,351","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-01-12","filed_date":"2016-01-12","scope":"insider"},{"id":8727588,"accession":"0001209191-15-074315","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-074315","line_url":"/filing/0001209191-15-074315#line-5","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Mirna Therapeutics, Inc.","issuer_ticker":"MIRN","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":857142.0,"shares_display":"857,142","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":2971517.0,"shares_owned_after_display":"2,971,517","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-10-06","filed_date":"2015-10-06","scope":"insider"},{"id":8917123,"accession":"0001181431-15-007922","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-15-007922","line_url":"/filing/0001181431-15-007922","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":378.0,"shares_display":"378","price_per_share":58.784,"price_display":"58.78","price_state":"stated","total_value":22220.352,"total_display":"22,220.35","total_whole":"22,220","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-03","filed_date":"2015-06-04","scope":"insider","n_lines":3},{"id":8782577,"accession":"0001181431-15-002012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-15-002012","line_url":"/filing/0001181431-15-002012#line-2","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":1888474.0,"shares_owned_after_display":"1,888,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-05","scope":"insider"},{"id":7051580,"accession":"0001181431-14-039771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-039771","line_url":"/filing/0001181431-14-039771#line-1","is_derivative":false,"issuer_cik":"0001037649","issuer_name":"INTERLEUKIN GENETICS INC","issuer_ticker":"ILIU","issuer_name_source":null,"issuer_url":"/issuer/0001037649","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19868965.0,"shares_display":"19,868,965","price_per_share":0.1003,"price_display":"0.10","price_state":"stated","total_value":1992857.1895,"total_display":"1,992,857.19","total_whole":"1,992,857","shares_owned_after":35298087.0,"shares_owned_after_display":"35,298,087","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-23","filed_date":"2014-12-29","scope":"insider"},{"id":6520299,"accession":"0001181431-14-034011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-034011","line_url":"/filing/0001181431-14-034011#line-2","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Dermira, Inc.","issuer_ticker":"DERM","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69112.0,"shares_display":"69,112","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":1105792.0,"total_display":"1,105,792.00","total_whole":"1,105,792","shares_owned_after":3502922.0,"shares_owned_after_display":"3,502,922","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-08","scope":"insider"},{"id":6723491,"accession":"0001181431-14-030049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-030049","line_url":"/filing/0001181431-14-030049","is_derivative":false,"issuer_cik":"0001122897","issuer_name":"CVENT INC","issuer_ticker":"CVT","issuer_name_source":null,"issuer_url":"/issuer/0001122897","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":378.0,"shares_display":"378","price_per_share":25.287592592592592,"price_display":"25.29","price_state":"stated","total_value":9558.71,"total_display":"9,558.71","total_whole":"9,559","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-22","filed_date":"2014-08-25","scope":"insider","n_lines":3},{"id":7066876,"accession":"0001181431-14-028434","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-028434","line_url":"/filing/0001181431-14-028434#line-2","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230769.0,"shares_display":"230,769","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2999997.0,"total_display":"2,999,997.00","total_whole":"2,999,997","shares_owned_after":1789420.0,"shares_owned_after_display":"1,789,420","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-06","filed_date":"2014-08-06","scope":"insider"},{"id":6782442,"accession":"0001181431-14-027152","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-14-027152","line_url":"/filing/0001181431-14-027152#line-5","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Roka BioScience, Inc.","issuer_ticker":"ROKA","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":383333.0,"shares_display":"383,333","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4599996.0,"total_display":"4,599,996.00","total_whole":"4,599,996","shares_owned_after":3216810.0,"shares_owned_after_display":"3,216,810","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-07-22","filed_date":"2014-07-22","scope":"insider"},{"id":6284157,"accession":"0001181431-14-003495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-003495","line_url":"/filing/0001181431-14-003495#line-1","is_derivative":false,"issuer_cik":"0001122897","issuer_name":"CVENT INC","issuer_ticker":"CVT","issuer_name_source":null,"issuer_url":"/issuer/0001122897","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":169887.0,"shares_display":"169,887","price_per_share":35.5,"price_display":"35.50","price_state":"stated","total_value":6030988.5,"total_display":"6,030,988.50","total_whole":"6,030,989","shares_owned_after":5994106.0,"shares_owned_after_display":"5,994,106","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-23","scope":"insider"},{"id":6780263,"accession":"0001181431-14-003136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-003136","line_url":"/filing/0001181431-14-003136#line-1","is_derivative":false,"issuer_cik":"0001122897","issuer_name":"CVENT INC","issuer_ticker":"CVT","issuer_name_source":null,"issuer_url":"/issuer/0001122897","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1132589.0,"shares_display":"1,132,589","price_per_share":35.5,"price_display":"35.50","price_state":"stated","total_value":40206909.5,"total_display":"40,206,909.50","total_whole":"40,206,910","shares_owned_after":6163993.0,"shares_owned_after_display":"6,163,993","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-16","filed_date":"2014-01-21","scope":"insider"},{"id":7049999,"accession":"0001181431-14-002531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-002531","line_url":"/filing/0001181431-14-002531#line-2","is_derivative":false,"issuer_cik":"0001219871","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001219871","owner_cik":null,"owner_name":"KOLLURI KRISHNA KITTU; NEA Partners 13, Limited Partnership; MOTT DAVID M; Viswanathan Ravi; KERINS PATRICK J; NEW ENTERPRISE ASSOCIATES 13 LP; NEA 13 GP, Ltd; Weller Harry R; DRANT RYAN D; BASKETT FOREST","owner_display_name":"KOLLURI KRISHNA KITTU","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":512500.0,"shares_display":"512,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":4100000.0,"total_display":"4,100,000.00","total_whole":"4,100,000","shares_owned_after":4093377.0,"shares_owned_after_display":"4,093,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-15","filed_date":"2014-01-15","scope":"insider"},{"id":4884109,"accession":"0001181431-13-059383","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-059383","line_url":"/filing/0001181431-13-059383","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49500.0,"shares_display":"49,500","price_per_share":19.78694727272727,"price_display":"19.79","price_state":"stated","total_value":979453.89,"total_display":"979,453.89","total_whole":"979,454","shares_owned_after":406500.0,"shares_owned_after_display":"406,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-18","scope":"insider","n_lines":2},{"id":4884099,"accession":"0001181431-13-059383","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-059383","line_url":"/filing/0001181431-13-059383","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357000.0,"shares_display":"357,000","price_per_share":19.659738851540617,"price_display":"19.66","price_state":"stated","total_value":7018526.77,"total_display":"7,018,526.77","total_whole":"7,018,527","shares_owned_after":357000.0,"shares_owned_after_display":"357,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-14","filed_date":"2013-11-18","scope":"insider","n_lines":3},{"id":4284371,"accession":"0001181431-13-034249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-034249","line_url":"/filing/0001181431-13-034249#line-1","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":560.0,"shares_display":"560","price_per_share":41.4476,"price_display":"41.45","price_state":"stated","total_value":23210.656,"total_display":"23,210.66","total_whole":"23,211","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-10","filed_date":"2013-06-11","scope":"insider"},{"id":5329723,"accession":"0001181431-13-033517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-033517","line_url":"/filing/0001181431-13-033517#line-2","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6000000.0,"total_display":"6,000,000.00","total_whole":"6,000,000","shares_owned_after":6033240.0,"shares_owned_after_display":"6,033,240","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-05","filed_date":"2013-06-07","scope":"insider"},{"id":4625377,"accession":"0001181431-13-022600","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-022600","line_url":"/filing/0001181431-13-022600#line-5","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Omthera Pharmaceuticals, Inc.","issuer_ticker":"OMTH","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196.0,"shares_display":"196","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":1568.0,"total_display":"1,568.00","total_whole":"1,568","shares_owned_after":156054.0,"shares_owned_after_display":"156,054","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-04-17","scope":"insider"},{"id":4625372,"accession":"0001181431-13-022600","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-022600","line_url":"/filing/0001181431-13-022600#line-4","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Omthera Pharmaceuticals, Inc.","issuer_ticker":"OMTH","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":5833213.0,"shares_owned_after_display":"5,833,213","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-04-17","scope":"insider"},{"id":2852311,"accession":"0001181431-12-055842","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-055842","line_url":"/filing/0001181431-12-055842#line-1","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Millennial Media Inc.","issuer_ticker":"MM","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1597787.0,"shares_display":"1,597,787","price_per_share":13.4425,"price_display":"13.44","price_state":"stated","total_value":21478251.7475,"total_display":"21,478,251.75","total_whole":"21,478,252","shares_owned_after":8196614.0,"shares_owned_after_display":"8,196,614","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-10-29","filed_date":"2012-10-30","scope":"insider"},{"id":3058453,"accession":"0001181431-12-039181","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-039181","line_url":"/filing/0001181431-12-039181#line-2","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1111111.0,"shares_display":"1,111,111","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":14999998.5,"total_display":"14,999,998.50","total_whole":"14,999,999","shares_owned_after":11499255.0,"shares_owned_after_display":"11,499,255","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-03","scope":"insider"},{"id":8829086,"accession":"0001181431-11-057268","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-057268","line_url":"/filing/0001181431-11-057268#line-3","is_derivative":false,"issuer_cik":"0001362942","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001362942","owner_cik":"0001362942","owner_name":"Weller Harry R","owner_display_name":"Weller Harry R","owner_url":"/insider/0001362942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1316299.0,"shares_display":"1,316,299","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":17111887.0,"total_display":"17,111,887.00","total_whole":"17,111,887","shares_owned_after":3419671.0,"shares_owned_after_display":"3,419,671","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Ten percent owner","n_filings":1,"first_seen":"2016-10-31","last_seen":"2016-10-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001037649","name":"INTERLEUKIN GENETICS INC","url":"/issuer/0001037649","role":"Ten percent owner","n_filings":2,"first_seen":"2014-12-29","last_seen":"2016-08-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001437402","name":"ARDELYX, INC.","url":"/issuer/0001437402","role":"Ten percent owner","n_filings":2,"first_seen":"2016-01-14","last_seen":"2016-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001491576","name":"TESARO, Inc.","url":"/issuer/0001491576","role":"Ten percent owner","n_filings":4,"first_seen":"2012-07-03","last_seen":"2016-03-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Ten percent owner","n_filings":3,"first_seen":"2013-06-07","last_seen":"2016-01-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001527599","name":"Mirna Therapeutics, Inc.","url":"/issuer/0001527599","role":"Ten percent owner","n_filings":1,"first_seen":"2015-10-06","last_seen":"2015-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001394319","name":"Tracon Pharmaceuticals, Inc.","url":"/issuer/0001394319","role":"Ten percent owner","n_filings":1,"first_seen":"2015-02-05","last_seen":"2015-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001557883","name":"Dermira, Inc.","url":"/issuer/0001557883","role":"Ten percent owner","n_filings":1,"first_seen":"2014-10-08","last_seen":"2014-10-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001122897","name":"CVENT INC","url":"/issuer/0001122897","role":"Ten percent owner","n_filings":3,"first_seen":"2014-01-21","last_seen":"2014-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001581720","name":"Loxo Oncology, Inc.","url":"/issuer/0001581720","role":"Ten percent owner","n_filings":1,"first_seen":"2014-08-06","last_seen":"2014-08-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001472343","name":"Roka BioScience, Inc.","url":"/issuer/0001472343","role":"Ten percent owner","n_filings":1,"first_seen":"2014-07-22","last_seen":"2014-07-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"GLYCOMIMETICS INC","url":"/issuer/0001253689","role":"Ten percent owner","n_filings":1,"first_seen":"2014-01-15","last_seen":"2014-01-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001477598","name":"Omthera Pharmaceuticals, Inc.","url":"/issuer/0001477598","role":"Ten percent owner","n_filings":1,"first_seen":"2013-04-17","last_seen":"2013-04-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001372375","name":"Millennial Media Inc.","url":"/issuer/0001372375","role":"Ten percent owner","n_filings":1,"first_seen":"2012-10-30","last_seen":"2012-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Ten percent owner","n_filings":1,"first_seen":"2011-11-22","last_seen":"2011-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001362942","retrieved_at":"2026-08-26T18:42:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}